These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1899716)

  • 21. Cytogenetic studies of rodents exposed to styrene by inhalation.
    Kligerman AD; Allen JW; Erexson GL; Morgan DL
    IARC Sci Publ; 1993; (127):217-24. PubMed ID: 8070867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse events after the use of benznidazole in infants and children with Chagas disease.
    Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
    Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenic evaluation of ronidazole.
    Hite M; Skeggs H; Noveroske J; Peck H
    Mutat Res; 1976 Nov; 40(4):289-304. PubMed ID: 796694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo dose-response relationship in bone-marrow cells of mice treated with adriamycin.
    Larramendy ML; Dulout FN; Bianchi NO; Olivero OA
    Mutat Res; 1980 Oct; 79(2):133-40. PubMed ID: 7432371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clastogenicity of diepoxybutane in bone marrow cells and male germ cells of mice.
    Adler ID; Kliesch U; Tiveron C; Pacchierotti F
    Mutagenesis; 1995 Nov; 10(6):535-41. PubMed ID: 8596474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of Chagas disease with benznidazole and thioctic acid].
    Roldán EJ
    Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigation of the genotoxic effect in bone marrow of Swiss albino mice exposed long-term to pyrimethamine.
    Tunca B; Egeli U; Aydemir N; Cecener G; Bilaloglu R
    Teratog Carcinog Mutagen; 2002; 22(6):393-402. PubMed ID: 12395401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen. 1. Studies with cyclophosphamide.
    Moore FR; Urda GA; Krishna G; Theiss JC
    Mutat Res; 1995 Oct; 335(2):191-9. PubMed ID: 7477050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of interactions of the antimalarial drugs chloroquine and mefloquine with NaNO2 and HgCl2 in rodents.
    Grisolia CK; Takahashi CS
    Mutat Res; 1994 Mar; 305(2):151-6. PubMed ID: 7510025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thioctic acid in the prevention of the toxic effects of benznidazole].
    Pérez Lloret A; Roldán EJ
    Medicina (B Aires); 1984; 44(1):108. PubMed ID: 6443012
    [No Abstract]   [Full Text] [Related]  

  • 34. Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Mazzeti AL; Gonçalves KR; Mendes PF; Bahia MT
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice.
    Novaes RD; Santos EC; Cupertino MC; Bastos DS; Oliveira JM; Carvalho TV; Neves MM; Oliveira LL; Talvani A
    Parasitol Res; 2015 Aug; 114(8):2873-81. PubMed ID: 25912691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease.
    Salvador F; Sánchez-Montalvá A; Martínez-Gallo M; Sala-Cunill A; Viñas L; García-Prat M; Aparicio G; Sao Avilés A; Artaza MÁ; Ferrer B; Molina I
    Clin Infect Dis; 2015 Dec; 61(11):1688-94. PubMed ID: 26265500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between experimental results in mammals and man. II. Cytogenetic analysis of bone-marrow cells after treatment of cytembena and cyclophosphamide- cytembena combination.
    Goetz P; Srám RJ; Kodýková I; Dohnalová J; Dostálová O; Bartova J
    Mutat Res; 1976 Nov; 41(1 spel. no):143-52. PubMed ID: 1037016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy].
    Gallerano RR; Sosa RR
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(2):135-62. PubMed ID: 12934232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species-specificity of pyrimethamine in the rodent bone marrow micronucleus test.
    Ono T; Sekiya T; Takahashi Y; Sasaki YF; Ohta T
    Mutat Res; 1997 Apr; 390(1-2):167-70. PubMed ID: 9150765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse systemic reaction to benznidazole.
    Coronel MV; Frutos LO; Muñoz EC; Valle DK; Rojas DH
    Rev Soc Bras Med Trop; 2017; 50(1):145-147. PubMed ID: 28327820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.